NCT05135481 is a NA clinical trial of phrenectomy in Ankyloglossia, sponsored by Princess Anna Mazowiecka Hospital, Warsaw, Poland.

Who is sponsoring NCT05135481?

NCT05135481 is sponsored by Princess Anna Mazowiecka Hospital, Warsaw, Poland.

What drugs are being tested in NCT05135481?

Interventions in NCT05135481: phrenectomy, Increased lactation support.

What condition does NCT05135481 study?

NCT05135481 studies Ankyloglossia, Breast Feeding, Exclusive, Lactation Failure, Tongue-tie.

Is NCT05135481 still recruiting?

NCT05135481 is currently withdrawn. Last updated 21 July 2022.

Last reviewed 2022-07-21 · How we verify

NCT05135481

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dedicated Lactation Support in Infants With Tongue - Tie; a Randomised Control Trial

Withdrawn NA Last updated 21 July 2022

What this trial tests

NA trial testing phrenectomy in Ankyloglossia. Withdrawn.

Timeline

8 March 2022

Primary endpoint
31 December 2022

31 March 2023

Quick facts

Lead sponsor	Princess Anna Mazowiecka Hospital, Warsaw, Poland
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Start date	8 March 2022
Primary completion	31 December 2022
Estimated completion	31 March 2023
Sites	1 location across Poland

Drugs / interventions tested

phrenectomy
Increased lactation support

Conditions studied

Ankyloglossia — all drugs for Ankyloglossia →
Breast Feeding, Exclusive — all drugs for Breast Feeding, Exclusive →
Lactation Failure — all drugs for Lactation Failure →
Tongue-tie — all drugs for Tongue-tie →

Sponsor

Princess Anna Mazowiecka Hospital, Warsaw, Poland

Who can join

Adults 1 Minute to 48 Hours, any sex, with Ankyloglossia or Breast Feeding, Exclusive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are registering a randomised controlled trial to assess whether dedicated, intensified lactation support is as good as frenotomy on the incidence of breastfeeding among term infants with ankyloglossia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ankyloglossia

Currently open trials in the same condition.

NCT07512765 — Ankyloglossia and Its Effects on Breastfeeding, Feeding and Speech Disorders. A Prospective Study From Birth to 4 Years · active not recruiting

Other Princess Anna Mazowiecka Hospital, Warsaw, Poland trials

Trials by the same sponsor.

NCT06199102 — The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants. · NA · not yet recruiting
NCT05117164 — Enteral Feeding in Infants With Duct Dependant Lesions. · NA · not yet recruiting
NCT05636410 — Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period · completed
NCT07434102 — Ultrasound Assessment for Predicting Optimal Umbilical Venous Catheter Placement · completed
NCT05574855 — Evaluation of Haemodynamic in Neonates Treated With Hypothermia" · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05135481 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Princess Anna Mazowiecka Hospital, Warsaw, Poland
Last refreshed: 21 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05135481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing